CMT Data Sources and Expert References

Line drawing of a card catalogue drawer with index cards standing in it; one card's tab shows a DNA double helix and another shows the outline of a foot and lower leg.

This is a curated directory of the expert databases and references that clinicians, geneticists, and researchers use for Charcot-Marie-Tooth disease (CMT) and related hereditary neuropathies: clinical overviews, gene and variant databases, disease naming systems, research networks, trial registries, and literature searches. Most were built for professionals. Each entry says who runs it, what it covers, how current it was when I checked, what you may do with it, and what it is good for.

A good way in is to start with a clinical overview, then follow a gene into the evidence and variant databases. If a term is unfamiliar, the Glossary explains most of them, and What Is CMT? is the plain-language introduction. For clinics, registries, and trials in Canada, see CMT Resources in Canada.

Not medical advice. These are reference and research tools. A database entry can’t tell you what your own genetic result means for you; a neurologist or genetic counsellor can.

Open data built from these sources: the Open CMT Gene Table lines up CMT genes with their subtype names and ClinGen evidence ratings. Search it and download it as Excel, CSV, or JSON on its data page, get the scripts and every source on GitHub, or cite a version by its DOI, 10.5281/zenodo.23371750.

On This Page

Clinical Overviews

  • GeneReviews: Charcot-Marie-Tooth Hereditary Neuropathy Overview, by neurologist Thomas D. Bird, in GeneReviews, the expert-written series published by the University of Washington on the US National Library of Medicine’s Bookshelf. It covers the CMT types, inheritance, nerve conduction cut-offs, the traditional and newer naming systems, and gene tables; Table 4 lists the CMT genes with their inheritance and nerve type. Current: last revised November 20, 2025 (first posted 1998). Access: free to read; the University of Washington holds copyright, so link to it rather than copying its tables. Use it for: the standard clinician’s overview of a CMT type or gene, with references.
  • Neuromuscular Disease Center, Washington University in St. Louis, written by neurologist Alan Pestronk, whose revision log runs from 1996 to 2026. Its Hereditary Motor Sensory Neuropathies page is one long, densely cross-linked page arranged by the traditional CMT types, giving the gene and chromosome location for each subtype, then clinical features, variant notes, and numbered references to the literature. Current: the CMT page is dated September 28, 2026, and cites papers from September 2026; the home page lists revisions made in October 2026. Access: free to read; no reuse licence is stated, so link rather than copy. Use it for: clinical detail on a specific subtype and a path into the papers behind it.
  • MedlinePlus Genetics: Charcot-Marie-Tooth Disease, from the US National Library of Medicine. A plain-language summary of symptoms, types, causes, frequency, and inheritance, with links to pages for individual genes. Current: last updated May 8, 2026. Access: free. Use it for: a readable starting point to share with family, linked to the genes involved.
  • Charcot-Marie-Tooth Disease, from the US National Institute of Neurological Disorders and Stroke (NINDS). A short overview of symptoms, types, inheritance, diagnosis, management, and research. Current: last reviewed September 2, 2026. Access: free. Use it for: a brief government overview and a sense of what NIH-funded research is looking at.

Gene–Disease Evidence

Dozens of genes have been linked to CMT, and more to related neuropathies, but the evidence for each is not equally strong. These sources rate or list that evidence.

  • ClinGen Charcot-Marie-Tooth Disease Gene Curation Expert Panel, part of the Clinical Genome Resource (ClinGen). The panel, chaired by Stephan Züchner and approved in December 2019, scores how strong the evidence is that each gene causes a given form of CMT or a related neuropathy: Definitive, Strong, Moderate, Limited, or Disputed. Search its results in ClinGen’s gene–disease validity curations. Current: in the download I took on October 10, 2026, the panel had 72 curations covering 70 genes (52 Definitive, 2 Strong, 13 Moderate, 4 Limited, 1 Disputed); the most recent was dated August 8, 2026. Access: free; ClinGen’s curations are released under a CC0 public domain dedication, and ClinGen asks for attribution and an access date. Use it for: how solid the evidence is that a gene causes CMT.
  • PanelApp: Hereditary Neuropathy or Pain Disorder (test R78), run by Genomics England for the NHS Genomic Medicine Service in England. This is the gene panel used for diagnostic testing of hereditary neuropathy, with each gene rated by expert reviewers as green (diagnostic grade), amber, or red. The older research panel, Hereditary Neuropathy (panel 85), is now marked as no longer actively maintained. Current: version 8.38, October 6, 2026: 375 genes, 231 of them green. Access: free to view, but the terms of use bar commercial use and use for diagnosis or medical decisions without a separate agreement. Use it for: seeing which genes a national diagnostic panel tests and how reviewers rate them.
  • Gene Table of Neuromuscular Disorders, prepared by Gisèle Bonne (Sorbonne Université–Inserm) and François Rivier (CHU de Montpellier), with the website maintained by Dalil Hamroun. It sorts every known neuromuscular disease gene into disease groups, one of which is hereditary motor and sensory neuropathies, and is published each year in Neuromuscular Disorders (2026 edition). Current: the website shows the 2026 table, updated May 18, 2026. Access: free to view; I found no open licence. Use it for: checking a gene against the whole neuromuscular field, including conditions other than CMT.
  • OMIM (Online Mendelian Inheritance in Man), edited at Johns Hopkins University. It has an entry for each gene and each numbered CMT subtype (such as CMT2A2 or CMT4B3), with its MIM number and a running summary of the literature, and groups related subtypes into “phenotypic series.” Current: OMIM is edited continuously, but it blocked my automated check on October 10, 2026, so I couldn’t record a date. Access: free to search. Johns Hopkins holds copyright, and its copyright terms require permission to copy OMIM for redistribution, so cite MIM numbers and link to entries rather than copying them. Use it for: the history of a numbered subtype and the papers that defined it.

Variants

  • ClinVar, from the US National Center for Biotechnology Information (NCBI). A public archive of what testing labs and expert panels have reported about whether specific variants cause disease, with a star rating for how well reviewed each report is. Current: the database was last updated October 5, 2026. Access: free to search and download. Use it for: seeing what labs have said about a specific variant, how much they agree, and whether it is still a variant of uncertain significance.
  • LOVD (Leiden Open Variation Database), shared installation. Gene-by-gene lists of variants from published cases and direct submissions, kept by volunteer curators; coverage varies a lot from gene to gene. Current: the PMP22 page linked here was last updated April 13, 2026, and lists 245 public variants, with one curator position vacant. Access: free to search; terms can vary by gene. Use it for: published variants in a gene and the individuals reported with them.

Gone quiet: the Antwerp mutation database. Older papers cite the Inherited Peripheral Neuropathies Mutation Database (IPNMDB) at the University of Antwerp, at molgen.ua.ac.be/CMTMutations. On October 10, 2026, its domain name didn’t resolve and the server didn’t respond. I couldn’t confirm whether it was formally retired or whether its data moved elsewhere. The Inherited Neuropathy Consortium also links to an Inherited Neuropathy Variant Browser from the Züchner lab, which didn’t load for me the same day.

Ontologies and Naming

CMT has several naming systems in use at once: the traditional numbered types (CMT1A, CMT2A2), the older HMSN labels, gene-based names, and database IDs. These sources help you match one name to another.

  • Mondo Disease Ontology, from the Monarch Initiative. It gives each disease a stable ID and cross-references it to OMIM, Orphanet, and other systems; ClinGen uses Mondo IDs. The link opens the term for Charcot-Marie-Tooth disease, MONDO:0015626, and its subtypes in the European Bioinformatics Institute’s Ontology Lookup Service. Current: release of October 6, 2026. Access: free, under a CC BY 4.0 licence. Use it for: matching one disease name across databases.
  • Human Phenotype Ontology (HPO), hosted by the Jackson Laboratory. Standard terms for clinical features, such as pes cavus or distal sensory loss, used by genetic labs and rare-disease databases to describe what a person has. Current: release of September 1, 2026. Access: free to use under HPO’s own licence, which I couldn’t read on October 10, 2026, because the page needs JavaScript; check it before reusing the terms. Use it for: precise names for signs and symptoms.
  • Orphanet: Charcot-Marie-Tooth Disease/Hereditary Motor and Sensory Neuropathy (ORPHA:166), coordinated by INSERM in Paris. Europe’s rare-disease reference, with ORPHA codes, prevalence estimates (1–5 per 10,000 for the CMT group as a whole), genes, expert centres, patient organizations, and registries. Current: I didn’t find an update date on the page. Access: free; the underlying data are released through Orphadata under CC BY 4.0. Use it for: ORPHA codes and European expert centres.
  • Updating the Classification of Inherited Neuropathies: Results of an International Survey, by Laurent Magy, Jean-Michel Vallat, and colleagues, Neurology, 2018. It reports support for their proposal to name each form of CMT by inheritance, type of nerve damage, and gene instead of by number: of 107 CMT specialists who answered, 65% said change was needed and the proposal was an improvement. GeneReviews now shows the system alongside the old one; for example, CMT2H appears as AR-CMTAx-GDAP1. In my reading, OMIM, Pestronk’s pages, and many of ClinGen’s disease labels still use the numbered names. Access: the abstract is free on PubMed. Use it for: understanding gene-based names like AR-CMTAx-GDAP1.

Research Networks and Registries

  • Inherited Neuropathy Consortium (INC). Its site describes it as a previously NIH-funded consortium of the Rare Diseases Clinical Research Network, now funded by the CMT Association. It runs natural-history studies at clinical sites and publishes CMT In-Depth and Testing for CMT. Current: the site is active; I didn’t find a page date. Access: free to read; study data aren’t public. Use it for: finding natural-history studies and the clinical research behind CMT outcome measures. See also INC in the glossary.
  • RDCRN Contact Registry, from the Rare Diseases Clinical Research Network, which is funded by the US National Institutes of Health. A contact registry, not a medical record: it keeps your contact details so its research groups can tell you about studies and surveys. INC’s site links to it. Current: open for enrolment on October 10, 2026. Access: free to join. Use it for: hearing about US research studies you might take part in.

In Canada: the Canadian Neuromuscular Disease Registry accepts people with CMT, and the Neuromuscular Disease Network for Canada keeps a Canadian neuromuscular trial database. Both are listed, with how to join, under Research, Registries, and Trials on CMT Resources in Canada.

Clinical Trials

  • ClinicalTrials.gov, from the US National Library of Medicine. A registry of clinical studies from around the world, with each study’s design, sites, status, and sometimes results. The link runs a search for CMT. Current: updated continuously; on October 10, 2026, the search returned 226 studies, 57 of them recruiting, including observational studies. Access: free. Use it for: checking a trial’s design, sponsor, sites, and status.
  • Clinical Trials in the European Union, the public site of the European Medicines Agency’s Clinical Trials Information System. It lists trials authorized in the European Union and European Economic Area, with their documents. Current: updated continuously. Access: free. Use it for: European trials, including some that aren’t on ClinicalTrials.gov.
  • Canadian Clinical Trial Search Portal, from Health Canada. It lists clinical trials of drugs and biologics that Health Canada has authorized. Current: I didn’t check its update schedule. Access: free. Use it for: confirming that a drug trial in Canada was authorized by Health Canada.

Literature

  • PubMed, from the US National Library of Medicine. The link runs a search for “charcot-marie-tooth,” newest first. Current: updated continuously; on October 10, 2026, the search returned 6,981 records. Access: free abstracts, with links to free full text where it exists. Use it for: the newest papers. Save the search in a free My NCBI account to get them by email.
  • Europe PMC, run by the European Bioinformatics Institute (EMBL-EBI). It includes PubMed’s records plus preprints and searchable full text of open-access articles. Current: updated continuously; on October 10, 2026, the same search returned 19,334 results. Access: free. Use it for: searching inside full texts and finding preprints.

What’s Missing

There is no open, cross-linked gene table for CMT. Each source above holds part of the picture: ClinGen rates the evidence, GeneReviews and OMIM keep the numbered names, PanelApp shows what a diagnostic panel tests, Mondo and Orphanet supply IDs, and ClinicalTrials.gov lists trials without sorting them by gene. Nothing public brings each gene’s names, inheritance, nerve type, evidence rating, and links together in one table that anyone may reuse. The lists don’t even agree on how many genes there are, partly because they count different things. CMT Blog plans to build such a table, starting from ClinGen’s public-domain curations. Suggestions are welcome.

Last checked October 10, 2026. Dates and counts are what each site showed that day; they change often. Found a dead link, or a resource I missed? Let me know.